SCHEMBL20745262

SCHEMBL20745262

O=C(O)N1CCC(F)(COCC2COCCO2)CC1

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20972639 0.85 USP2 (0.46)
SCHEMBL20972642 0.85 USP2 (0.46)
SCHEMBL20972701 0.76 KDM4E (0.32) KDM4EALDH1A1LMNAMAPT
SCHEMBL20745643 0.76 KDM4E (0.32) KDM4EALDH1A1LMNAMAPT
SCHEMBL20972712 0.76 KDM4E (0.32) KDM4EALDH1A1LMNAMAPT
SCHEMBL20745752 0.76 CHRM2 (0.33)
SCHEMBL20745753 0.76 CHRM2 (0.33)
SCHEMBL20972563 0.75 CHRM2 (0.32)
SCHEMBL20972699 0.75 CHRM2 (0.32)
SCHEMBL20745519 0.75 CHRM2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3652184-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE AbbVie Inc. (US) 2020-05-20 EP disclosed
WO-2019035911-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC. (US) 2019-02-21 WO disclosed